FY2025 · ended Dec 31, 2025 · Revenue $13.55M · Filed Mar 26, 2026
CapsoVision, Inc (CV) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $13.6 million and a net loss of $25.3 million. Free cash flow was -$23.0 million.
Revenue (TTM)
$13.89M
Net income (TTM)
$-29.83M
Operating cash flow (TTM)
$-27.82M
Free cash flow (TTM)
$-27.89M
EPS (TTM)
$-0.63
Dividend per share
None
Shares outstanding
49.84M
Net cash
—
Operating margin
-217.1%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- CV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Saratoga, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1378325
- Former names
- Capso Vision Inc (until Feb 21, 2014)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
|---|---|
| Revenue | $13.6M |
| Operating income | -$25.5M |
| Net income | -$25.3M |
| Diluted EPS | -$1.03 |
| Operating cash flow | -$22.9M |
| Free cash flow | -$23.0M |
| Total assets | $18.2M |
| Total liabilities | $4.9M |
| Stockholders' equity | $13.3M |
| Total debt | $887,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 18, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Other events
|
Aug 18, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 2, 2026 | Jul 1, 2026 |
All 141 CapsoVision, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.